Genentech, Inc.

Genentech, Inc.

Genentech, Inc.

Overview
Date Founded

1986

Headquarters

1 DNA Way,Mailstop 258A,South San Francisco, CA 94080

Type of Company

Private

Employees (Worldwide)

11.2K

Industries

Pharmaceuticals
Industrial Machinery & Manufacturing
Biotechnology

Company Description

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Website

http://www.gene.com

Contact Data
Trying to get in touch with decision makers at Genentech, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
PR Newswire
February 25, 2020
Halozyme Announces FDA Has Accepted Biologics License Application For Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Enhanze® Technology; - U.S. Food Drug and Administration Expected to Decide on Approval by October 18, 2020 -
Business Wire
February 25, 2020
FDA Accepts Genentech's Biologics License Application for Fixed-dose Subcutaneous Combination of Perjeta and Herceptin for HER2-Positive Breast Cancer; - Fixed-dose combination is administered under the skin in just minutes, compared to hours with intrave
Business Wire
February 24, 2020
Global Cystic Fibrosis Therapeutics Market (2019 to 2026) - CAGR of 9.2% Expected During the Forecast Period - ResearchAndMarkets.com
PR Newswire
February 21, 2020
Leaders from 24 companies in the US Pharmaceutical Supply Chain collaborate to submit the MediLedger DSCSA Pilot Project Final Report to the FDA, proposing blockchain for an interoperable track and trace system for US prescription drugs
PR Newswire
February 19, 2020
Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Alexander Hardy

Chief Executive Officer

Sean Johnston

Senior Vice President & General Counsel

Levi Garraway

Chief Medical Officer & Executive Vice President

Edward Harrington

Chief Financial Officer & Head of Pharma Finance, North America

William N. Anderson

Chief Executive Officer, Roche Pharmaceuticals

Jerry Cacia

Global Head, Pharmaceutical Technical Development

Michael D. Varney

Executive Vice President, Genentech Research & Early Development

Sandra J. Horning

Executive Vice President, Global Development & Chief Medical Officer

Nancy Vitale

Senior Vice President of Human Resources & Regional Human Resources Head, North America

Cynthia Burks

Senior Vice President of Human Resources, Genentech & Regional Human Resources Head, North America

Board of Directors
Severin Schwan

Chief Executive Officer at Roche Holding AG

André Hoffmann

Treasurer & Director at Fondation Auxiliaire du Conservatoire botanique de la Ville de

Alan Hippe

Chief Financial & Information Technology Officer at Roche Holding AG

John Irving Bell

Regius Professor of Medicine at Oxford University Medical School

Alexander Hardy

Chief Executive Officer at Genentech, Inc.

William N. Anderson

Chief Executive Officer, Roche Pharmaceuticals at Genentech, Inc.

Richard P. Lifton

President at The Rockefeller University

Sean Johnston

Senior Vice President & General Counsel at Genentech, Inc.

Frederick Kentz

Senior Vice President, Secretary & Chief Compliance Officer, Head of Legal Affairs, North America at Genentech, Inc.

Trending People
US Defense Logistics Agency
-DLA: Defense Supply Center Columbus' African American History Program features... - ENP Newswire
Cyber Defense Media Group
Stellar Cyber Named Winner of the Coveted InfoSec Awards during RSA Conference 2... - Business Wire
The Los Angeles Lakers, Inc.
This photo of an injured Kobe Bryant willing himself to play sums up the Mamba m... - CNN
Intuit, Inc.
A boom, a bust, a reckoning, a race: four takes on today’s startup market - TechCrunch
WikiLeaks
Hero or criminal? Court hears 2 views of WikiLeaks' Assange - Associated Press
Trending Organizations
US Defense Logistics Agency
-DLA: Defense Supply Center Columbus' African American History Program features... - ENP Newswire
Cyber Defense Media Group
Stellar Cyber Named Winner of the Coveted InfoSec Awards during RSA Conference 2... - Business Wire
The Los Angeles Lakers, Inc.
This photo of an injured Kobe Bryant willing himself to play sums up the Mamba m... - CNN
Intuit, Inc.
A boom, a bust, a reckoning, a race: four takes on today’s startup market - TechCrunch
WikiLeaks
Hero or criminal? Court hears 2 views of WikiLeaks' Assange - Associated Press
Paths to Genentech, Inc.
Potential Connections via
Relationship Science
You
Genentech, Inc.
Recent Transactions
Details Hidden

Genentech, Inc., Roche Holding AG purchase Jecure Therapeutics, Inc. from Versant Venture Management LLC

Details Hidden

Genentech, Inc., Roche Holding AG purchase Seragon Pharmaceuticals, Inc. from Topspin Management LLC, Aisling Capital, OrbiMed Advisors Private Equity, The Column Group LLC, venBio Partners LLC

Details Hidden

Genentech, Inc., Roche Holding AG purchase RQx Pharmaceuticals, Inc. from Avalon Ventures Management LLC, Correlation Management LLC

Transaction Advisors
Legal Advisor
Wilson Sonsini Goodrich & Rosati PC

Advised onRoche Holding AG purchases Genentech, Inc.

Investment Advisor
Goldman Sachs & Co. LLC

Advised onRoche Holding AG purchases Genentech, Inc.

Selling Group Member
Bank am Bellevue AG

Advised onGenentech, Inc. issued USD Common Stock

Legal Advisor
Martin W. Korman

Advised onRoche Holding AG purchases Genentech, Inc.

Legal Advisor
Aaron J. Rigby

Advised onGenentech, Inc., Roche Holding AG purchase Seragon Pharmaceuticals, Inc. from Topspin Management LLC, Aisling Capital, OrbiMed Advisors Private Equity, The Column Group LLC, venBio Partners LLC

Global Co-Chairman, Mergers & Acquisitions Group
Charles M. Nathan

Advised onRoche Holding AG purchases Genentech, Inc.

Advisors & Consultants
Legal Advisor
Nathaniel P. Gallon

Managing Partner at Hogan & Lovells LLP

Legal Advisor
David J. Berger

Partner at Wilson Sonsini Goodrich & Rosati PC

Legal Advisor
Boris Feldman

Partner at Wilson Sonsini Goodrich & Rosati PC
Key Stats and Financials As of 2019
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$3.4B
Non-Profit Donations & Grants
$30K - $100K
2018
Cold Spring Harbor Laboratory

$100K +
2018
National Coalition for Cancer Survivorship

$100K - $250K
2013
The Brookings Institution

Political Donations
$250
2014
Vincent Fort

$1,000
2014
Ted W. Lieu

$500
2014
Brandon L. Beach

Investments
Details Hidden
Cellective Therapeutics, Inc.

Cellective Therapeutics, Inc. provides biopharmaceuticals products. It develops monoclonal antibodies for the treatment of oncology and autoimmune diseases. Cellective Therapeutics products include monoclonal antibodies that target the B-cell antigens CD19, CD20 and CD22 are in preclinical stage programs. It was founded by Thomas F. Tedder and Alter E. Geller in May, 2003 and is headquartered in Durham, NC

Details Hidden
Horizon Discovery Group PLC

Horizon Discovery Group Plc is a gene editing company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in 2005 and is headquartered in Cambridge, the United Kingdom.

Investors
Details Hidden
Nicolas Sommer

Professional at Genentech, Inc.

Awards & Honors
Rank #6
2017
Fortune Magazine - The 100 Best Companies to Work For
Sponsored by Fortune Magazine

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Genentech, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Genentech, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Genentech, Inc..